• Produktbild: The Tumor Microenvironment
  • Produktbild: The Tumor Microenvironment

The Tumor Microenvironment

Fr. 241.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

09.09.2010

Herausgeber

Rebecca G. Bagley

Verlag

Springer Us

Seitenzahl

770

Maße (L/B/H)

24.1/16/4.5 cm

Gewicht

1420 g

Auflage

2010

Sprache

Englisch

ISBN

978-1-4419-6614-8

Beschreibung

Portrait

Rebecca Bagley is a senior scientist at Genzyme Corporation and has worked in the biotechnology industry for 20 years with degrees in biology from Wellesley College and Harvard University. Her expertise in drug development spans a wide range of approaches including immunotherapies, gene and protein therapies, and small molecule delivery with publications in journals such as Molecular Cancer Therapeutics, Cancer Research, and Microvascular Research . Her current research focuses on stem cells, tumor vasculature, and target validation.

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

09.09.2010

Herausgeber

Rebecca G. Bagley

Verlag

Springer Us

Seitenzahl

770

Maße (L/B/H)

24.1/16/4.5 cm

Gewicht

1420 g

Auflage

2010

Sprache

Englisch

ISBN

978-1-4419-6614-8

Herstelleradresse

Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: The Tumor Microenvironment
  • Produktbild: The Tumor Microenvironment
  • Preface
    Bruce Zetter, PhD

    Table of Contents:
    PHYSIOLOGICAL PARAMETERS

    1. Combination Strategies Targeting Hypoxia Inducible Factor 1 (HIF-1) for Cancer Therapy
    Annamaria Rapisarda, PhD and Giovanni Melillo, MD

    2. New Insights into Regulation of Tumor pH by Carbonic Anhydrases
    Pawel Swietach,DPhil, Adrian L. Harris, DPhil/MBChB, and Richard D. Vaughan-Jones1,PhD

    3. Hypoxia, Gene Expression and Metastasis
    Olga V. Razorenova, PhD and Amato J. Giaccia, PhD

    4. Molecular Mechanisms Regulating Expression and Function of Cancer-Associated Carbonic Anhydrase IX
    Jaromir Pastorek, PhD and Silvia Pastorekova, PhD

    5. Glycolytic Pathway as a Target for Tumor
    Inhibition
    Weiqin Lu, PhD and Peng Huang, MD/PhD

    CELLULAR COMPONENTS

    I. MALIGNANT CELLS

    6. Aberrant DNA Methylation in Cancer Cells
    Toshikazu Ushijima, MD/PhD

    7. DNA Repair and Redox Signaling
    Mark R. Kelley, PhD, Millie M Georgiadis, PhD, and Melissa L. Fishel, PhD

    8. Cancer Stem Cells and Microenvironment
    Mario Federico, MD and Antonio Giordano, MD/PhD

    9. Epithelial-Mesenchymal Transition in Development and Diseases
    Yadi Wu,PhD and Binhua P. Zhou, MD/PhD

    10. Invasion and Metastasis
    Douglas M. Noonan, PhD, Giuseppina Pennesi, MD, and Adriana Albini, PhD

    11. Dormancy of Disseminated Tumor Cells: Reciprocal Crosstalk with the Microenvironment
    Paloma Bragado, PhD, Aparna C. Ranganathan, PhD, and Julio Aguirre-Ghiso, PhD

    II. VASCULATURE AND STROMA

    12. Impact of Endothelial Progenitor Cells on Tumor Angiogenesis and Outcome of Antiangiogenic Therapy: New Perspectives on an Ongoing Controversy
    Robert S. Kerbel1, PhD, Francesco Bertolini, MD/PhD, and Yuval Shaked, PhD

    13. Bone Marrow Derived Mesenchymal Stem/Stromal Cells and Tumor Growth
    Pravin J. Mishra, MS and Debabrata Banerjee, PhD

    14. Integrin Signaling in Lymphangiogenesis
    Barbara Garmy-Susini, PhD

    15. Role of Pericytes in Resistance to Anti-Angiogenic Therapy
    Koji Matsuo, MD, Chunhua Lu1, MD/PhD Mian M K. Shazad, MS/MD, Robert L. Coleman,MD, and Anil K. Sood, MD

    16. Tumour-Promoting Stromal Fibroblasts in Human Carcinomas
    Urszula M. Polanska, Msc/PhD, Kieran T. Mellody, BSc./MPhil., and Akira Orimo, MD/PhD*

    III. IMMUNE-MEDIATED CELLS

    17. Mast cells and tumor microenvironment
    Theoharis C. Theoharides, MS/MD/PhD, Konstantinos-Dionysios Alysandratos, MD, Asimenia Angelidou, MD, and Bodi Zhang, MD/MPH

    18. Macrophages in the Tumor Microenvironment
    Monica Escorcio-Correia, PhD and Thorsten Hagemann, MD/PhD

    19. The Prognostic Significance of Tumor-Infiltrating Lymphocytes
    Ping Yu, MD/PhD and Yang-Xin Fu, MD/PhD

    20. The Pro-Inflammatory Milieu and Pre-Malignant Epithelial Initiation
    Adam Yagui-Beltran, MD, Lisa M. Coussens, PhD, Qizi Tang, PhD, and David Jablons, MD

    21. Natural Killer Cells for Adoptive Immunotherapy
    Jonathan E. Benjamin, MD/PhD and Sally Arai, MD

    EXTRACELLULAR MATRIX

    22. Fibronectin
    Andreas Menrad, PhD

    23. Collagen in Cancer
    Janelle L. Lauer, PhD and Gregg B. Fields, PhD

    24. Integrins and Cancer
    Laurie G. Hudson,PhD and M. Sharon Stack, PhD

    25. Matrix Metalloproteinases and Cancer Cell Invasion/Metastasis
    Stanley Zucker, MD and Jian Cao, PhD

    26. Tetraspanins and Cancer Metastasis
    Margot Zoller, PhD

    SECRETED PROTEINS

    27. Chemokines and Metastasis
    Kalyan C. Nannuru, PhD, Seema Singh, PhD, and Rakesh K. Singh, PhD

    28. Transforming Growth Factor-? in Lung Cancer, Carcinogenesis and Metastasis
    Sonia B. Jakowlew, PhD

    29. Cooperative Interactions Between Integrins and Growth Factors in Pathological Angiogenesis
    Jennifer M. Roth, MS, Eric Tweedie, BS, and Peter C. Brooks, PhD

    30. The Extracellular Matrix and the Growth and Survival of Tumors
    Yves DeClerck, MD

    31. Secreted Growth Factors as Therapeutic Targets
    Beverly A. Teicher, PhD

    32. Adrenomedullin in Tumor Development
    Rebecca G. Bagley, MS